Status: Recruiting
Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder
To evaluate the superiority of cognitive behavioral therapy using the Aurora® digital medical device + conventional drug treatment, compared to conventional drug treatment alone, in reducing anxiety symptoms, as assessed by the change in the GAD-7 scale at 12 weeks of treatment, relative to baseline.
Participants needed: 162
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Psicofarma, S.A. De C.V.Updated: Apr 1, 2026Locations: 1
Eligibility criteria
Men and women aged ≥18 and ≤65 years. [+3]
Concomitant alcohol use disorder or recreational drug use disorder. [+22]